Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #23829 on Intellipharmaceutics International Inc. (IPCI)
AngeloFoca
02/15/17 2:27 PM
#23830 RE: fabius #23829
They just have to stick with their own advertised strategy
Our drug delivery technology licensing program is particularly well suited to the requirements of owners of new chemical entities (NCE's) whose short half lives make multiple dosing per day necessary. Our proprietary technologies offer the means to add new dimensions to these products by enabling once a day delivery